Two Democratic congressmen are set to introduce legislation Thursday aimed at lowering drug prices for millions of service members, veterans and military families.
Reps. Eugene Vindman, D-Va., and Pat Ryan, D-N.Y., both retired U.S. Army veterans and members of the House Armed Services Committee, are advancing a bill they dubbed the MISSION RX Act.
Their proposal is designed to allow Tricare beneficiaries and Department of Veterans Affairs patients to pay for prescription drugs at whichever is the lower of two prices: the rate negotiated by the Centers for Medicare & Medicaid Services, or CMS, or the cost offered through their existing coverage.
The bottom line, the congressmen say, is that anyone covered by Tricare or the VA would pay the lowest government-negotiated price.
Right now, only people enrolled in Medicare get to pay the rate for certain drugs set by the CMS.
This option does not automatically extend to those who are part of other federal health programs. The basic framework to lower drug costs for Medicare recipients was part of the Inflation Reduction Act, passed in 2022 under then-President Joe Biden.
“After serving 25 years in uniform, I know firsthand the sacrifices our service members, veterans and military families make every single day,” Vindman said in an exclusive statement to Military Times. “The last thing any of them should have to worry about is whether they can afford the prescription drugs they need.”
“The veterans and service members I represent in Virginia’s Seventh District have earned every benefit this nation can give them. That’s why I’m leading this commonsense effort to reduce the crushing cost of prescription drugs for those who have served and sacrificed,” he added.
Vindman and Ryan’s push faces an uncertain future in the House, where Republicans hold a slim majority. The bill has four co-sponsors so far, all of whom are Democrats: Reps. Chris Deluzio of Pennsylvania, Maggie Goodlander of New Hampshire, Chrissy Houlahan of Pennsylvania and Bill Keating of Massachusetts.
It also has the support of a number of key organizations, including the Veterans of Foreign Wars, the Marine Corps League, the Fleet Reserve Association, Air Force Sergeants Association and Commissioned Officers Association Public Health Service.
Before they entered Congress, Vindman and Ryan built their careers in the Army during the post-9/11 wars, each deploying to Iraq. Vindman began as a paratrooper and infantry officer, before going on to serve as a Judge Advocate General’s Corps attorney. Ryan, for his part, worked as an intelligence officer, earning two Bronze Star Medals.
“Military families have sacrificed so much for our country — it’s absolutely unacceptable that they’re being forced to pay more than other Americans for the same medication,” Ryan said in a statement.
“Our bill corrects this egregious oversight by ensuring that military families have access to the same lower drug prices that others do. Especially amid rising healthcare costs nationwide, leaving military families to bear the burden is simply un-American,” he continued. “They’ve stepped up and sacrificed for us — now we need to do right by them.”
The legislation, if enacted, would boost the savings for American taxpayers from lower drug costs. CMS already estimates that the original Biden-era measures could save $6 billion annually.
Tanya Noury is a reporter for Military Times and Defense News, with coverage focusing on the White House and Pentagon.
Read the full article here
